生物活性 | |||
---|---|---|---|
描述 | Ingenol is an extremely weak PKC (protein kinase C) activator and has been found to induce apoptosis and act as an anticancer agent. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01541553 | Actinic Keratosis | Phase 3 | Completed | - | - |
NCT02531295 | HIV Human Imm... 展开 >>unodeficiency Virus 收起 << | Phase 1 | Recruiting | November 2020 | United States, Utah ... 展开 >> University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Adam M Spivak, MD 801-585-2031 adam.spivak@hsc.utah.edu Contact: Zachary Mitchell (801) 587-7467 zachary.mitchell@hsc.utah.edu Principal Investigator: Sulggi A Lee, MD PhD Principal Investigator: Adam M Spivak, MD Sub-Investigator: Steven G Deeks, MD 收起 << |
NCT01541553 | - | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.87mL 0.57mL 0.29mL |
14.35mL 2.87mL 1.44mL |
28.70mL 5.74mL 2.87mL |
参考文献 |
---|